Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults

clinical trial

Wikidata entity: Q63573290



Quantities

P2899minimum age18
P1132number of participants1500

P6099 clinical trial phase ... Q42824440 (phase II clinical trial) phase II clinical trial
P6099 clinical trial phase ... Q42824827 (phase III clinical trial) phase III clinical trial
P17 country ... Q30 (United States) United States
P582 end time ... 2019-09-30 ???
P31 instance of ... Q30612 (clinical trial) clinical trial
P6153 research site ... Q30269430 (Anaheim Clinical Trials) Anaheim Clinical Trials
P6153 research site ... Q30269657 (Coastal Carolina Research Center) Coastal Carolina Research Center
P6153 research site ... Q30269674 (Collaborative Neuroscience Network) Collaborative Neuroscience Network
P6153 research site ... Q30269704 (Meridien Research) Meridien Research
P6153 research site ... Q30269903 (Heartland Research Associates) Heartland Research Associates
P6153 research site ... Q30270033 (PMG Research) PMG Research
P6153 research site ... Q30270193 (Meridian Clinical Research) Meridian Clinical Research
P6153 research site ... Q30270303 (Riverside Clinical Research) Riverside Clinical Research
P6153 research site ... Q30270309 (Premiere Research Institute) Premiere Research Institute
P6153 research site ... Q30270449 (Sundance Clinical Research) Sundance Clinical Research
P6153 research site ... Q30282378 (Northwest Clinical Research Center) Northwest Clinical Research Center
P6153 research site ... Q50039766 (Regeneris Medical) Regeneris Medical
P580 start time ... 2018-11-14 ???
P8363 study type ... Q78089383 (interventional study) interventional study
P1476 title Monolingualtext A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Migraine Prevention ???

External Ids
P3098ClinicalTrials.gov IDNCT03732638

Why not click here or view trends?

log id: 5816660